Promoter sequence differences may determine maximal hemoglobin F levels in 5-azacytidine treated baboons.
Lavelle
D E
DE
Department of Medicine, University of Illinois College of Medicine, Chicago.
DeSimone
J
J
D000818:Animals; D001374:Azacitidine / Q000494:pharmacology*; D001483:Base Sequence; D005319:Fetal Hemoglobin / Q000096:biosynthesis / Q000235:genetics*; D005786:Gene Expression Regulation / Q000187:drug effects*; D005914:Globins / Q000096:biosynthesis / Q000235:genetics*; D006801:Humans; D008969:Molecular Sequence Data; D010215:Papio / Q000235:genetics; D011401:Promoter Regions, Genetic; D012689:Sequence Homology, Nucleic Acid; D013045:Species Specificity
D005914:Globins; D005319:Fetal Hemoglobin; D001374:Azacitidine